| Secondary |
| Drug Use For Unknown Indication |
32.4% |
| Product Used For Unknown Indication |
12.7% |
| Cancer Pain |
9.0% |
| Analgesic Therapy |
6.8% |
| Pain |
6.8% |
| Rheumatoid Arthritis |
5.4% |
| Chemotherapy |
4.5% |
| Psoriatic Arthropathy |
2.5% |
| Atrial Fibrillation |
2.0% |
| Hiv Infection |
2.0% |
| Antiphospholipid Syndrome |
1.7% |
| Arthritis |
1.7% |
| Colitis Ulcerative |
1.7% |
| Crohn's Disease |
1.7% |
| Hypertension |
1.7% |
| Myalgia |
1.7% |
| Prophylaxis |
1.7% |
| Renal Failure |
1.7% |
| Ill-defined Disorder |
1.4% |
| Anaemia |
1.1% |
|
| Urticaria |
13.8% |
| Anaphylactic Reaction |
10.3% |
| Weight Increased |
8.6% |
| Thrombocytopenia |
6.9% |
| Glomerulonephritis |
5.2% |
| Renal Failure Acute |
5.2% |
| Toxic Epidermal Necrolysis |
5.2% |
| Tubulointerstitial Nephritis |
5.2% |
| Upper Gastrointestinal Haemorrhage |
5.2% |
| Adverse Event |
3.4% |
| Angioedema |
3.4% |
| Asthma |
3.4% |
| Cytomegalovirus Infection |
3.4% |
| Gastrointestinal Haemorrhage |
3.4% |
| Hallucination |
3.4% |
| Myalgia |
3.4% |
| Nodule |
3.4% |
| Vomiting |
3.4% |
| Abdominal Pain Upper |
1.7% |
| Alanine Aminotransferase Increased |
1.7% |
|
| Concomitant |
| Rheumatoid Arthritis |
22.5% |
| Drug Use For Unknown Indication |
17.9% |
| Product Used For Unknown Indication |
13.9% |
| Ankylosing Spondylitis |
9.2% |
| Pain |
3.9% |
| Arthralgia |
3.6% |
| Contraception |
3.3% |
| Multiple Sclerosis |
3.2% |
| Polyarthritis |
3.2% |
| Prophylaxis |
2.3% |
| Antiemetic Supportive Care |
2.2% |
| Hypertension |
2.2% |
| Psoriatic Arthropathy |
2.2% |
| Oral Contraception |
2.0% |
| Depression |
1.6% |
| Herpes Zoster |
1.6% |
| Psoriasis |
1.6% |
| Back Pain |
1.3% |
| Atrial Fibrillation |
1.2% |
| Osteoporosis |
1.2% |
|
| Vomiting |
9.3% |
| Pulmonary Embolism |
8.4% |
| Gastrointestinal Haemorrhage |
7.5% |
| Sepsis |
7.5% |
| Renal Failure Acute |
6.5% |
| Weight Decreased |
5.6% |
| Conversion Disorder |
4.7% |
| Death |
4.7% |
| Nausea |
4.7% |
| Pulmonary Tuberculosis |
4.7% |
| Treatment Failure |
4.7% |
| Tuberculosis |
4.7% |
| Gallbladder Disorder |
3.7% |
| Infusion Related Reaction |
3.7% |
| Stomatitis |
3.7% |
| Traumatic Haematoma |
3.7% |
| Urinary Tract Infection |
3.7% |
| Adenosquamous Cell Lung Cancer |
2.8% |
| Arthralgia |
2.8% |
| Breast Cancer |
2.8% |
|
| Interacting |
| Product Used For Unknown Indication |
42.9% |
| Drug Use For Unknown Indication |
28.6% |
| Pneumonia |
28.6% |
|
| Weight Increased |
75.0% |
| Haemorrhage |
12.5% |
| Hyperkalaemia |
12.5% |
|
